Stevanato Group SPA (Stevanato Group SPA) FCF Margin % : -23.99% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stevanato Group SPA FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Stevanato Group SPA's Free Cash Flow for the three months ended in Dec. 2023 was $-84 Mil. Stevanato Group SPA's Revenue for the three months ended in Dec. 2023 was $350 Mil. Therefore, Stevanato Group SPA's FCF Margin % for the quarter that ended in Dec. 2023 was -23.99%.

As of today, Stevanato Group SPA's current FCF Yield % is -4.96%.

The historical rank and industry rank for Stevanato Group SPA's FCF Margin % or its related term are showing as below:

STVN' s FCF Margin % Range Over the Past 10 Years
Min: -31.02 Med: -5.84 Max: 9.01
Current: -30.97

During the past 6 years, the highest FCF Margin % of Stevanato Group SPA was 9.01%. The lowest was -31.02%. And the median was -5.84%.

STVN's FCF Margin % is ranked worse than
66.14% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: -7.13 vs STVN: -30.97

Stevanato Group SPA FCF Margin % Historical Data

The historical data trend for Stevanato Group SPA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stevanato Group SPA FCF Margin % Chart

Stevanato Group SPA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-5.84

9.01

2.39

-14.21

-31.02

Stevanato Group SPA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial												-2.90	-38.51	-27.16	-36.40	-23.99

Competitive Comparison of Stevanato Group SPA's FCF Margin %

For the Medical Instruments & Supplies subindustry, Stevanato Group SPA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stevanato Group SPA's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SPA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Stevanato Group SPA's FCF Margin % falls into.

Stevanato Group SPA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Stevanato Group SPA's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-367.196	/	1183.592
	=	-31.02 %

Stevanato Group SPA's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-83.899	/	349.661
	=	-23.99 %

Stevanato Group SPA FCF Margin % Related Terms

Thank you for viewing the detailed overview of Stevanato Group SPA's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Stevanato Group SPA (Stevanato Group SPA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SPA (NYSE:STVN) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

87N:Germany

Address

Via Molinella 17, Piombino Dese, Padua, ITA, 35017

Website

https://www.stevanatogroup.com

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% from South America. It has two segments Biopharmaceutical and Diagnostic Solutions and Engineering.